MedPath
HSA Approval

FOBAN CREAM 2% w/w

SIN11036P

FOBAN CREAM 2% w/w

FOBAN CREAM 2% w/w

July 20, 1999

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.
Licence HolderZUELLIG PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

**RECOMMENDED DOSAGE :** After washing, apply to the affected area twice daily as directed by your doctor or pharmacist.

TOPICAL

Medical Information

**INDICATIONS :** Skin lesions primarily or secondarily infected with _Staphylococcus_ or _Streptococcus_.

**CONTRAINDICATIONS :** Known hypersensitivity to Fusidic acid, its salts and propylene glycol.

D06AX01

fusidic acid

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

HOE PHARMACEUTICALS SDN BHD

Active Ingredients

FUSIDIC ACID

2% w/w

Fusidic acid

Documents

Package Inserts

FOBAN CREAM PI.pdf

Approved: June 14, 2023

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.